Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

OBJECTIVE: HCV infection is a leading cause of chronic liver disease and a major indication for liver transplantation. Although direct-acting antivirals (DAAs) have much improved the treatment of chronic HCV infection, alternative strategies are needed for patients with treatment failure. As an esse...

Descripción completa

Detalles Bibliográficos
Autores principales: Colpitts, Che C, Tawar, Rajiv G, Mailly, Laurent, Thumann, Christine, Heydmann, Laura, Durand, Sarah C, Xiao, Fei, Robinet, Eric, Pessaux, Patrick, Zeisel, Mirjam B, Baumert, Thomas F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868241/
https://www.ncbi.nlm.nih.gov/pubmed/28360099
http://dx.doi.org/10.1136/gutjnl-2016-312577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868241/
https://www.ncbi.nlm.nih.gov/pubmed/28360099
http://dx.doi.org/10.1136/gutjnl-2016-312577

Ejemplares similares